Related references
Note: Only part of the references are listed.Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle
Yingying Cong et al.
JOURNAL OF VIROLOGY (2020)
Human adenovirus binding to host cell receptors: a structural view
Aleksandra Cecylia Stasiak et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2020)
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Aiping Wu et al.
CELL HOST & MICROBE (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
Xintian Xu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies
Michael Lim et al.
PHARMACEUTICS (2020)
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
Abishek Wadhwa et al.
PHARMACEUTICS (2020)
Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
Amy S. Espeseth et al.
NPJ VACCINES (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review
Esteban Ortiz-Prado et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)
Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R. F. Smith et al.
NATURE COMMUNICATIONS (2020)
Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity
Sebastian Ols et al.
CELL REPORTS (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open -label, phase 1 trial
Till Koch et al.
LANCET INFECTIOUS DISEASES (2020)
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
Lynda Coughlan
FRONTIERS IN IMMUNOLOGY (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
mRNA Vaccines Encoding the HA Protein of Influenza A H1N1 Virus Delivered by Cationic Lipid Nanoparticles Induce Protective Immune Responses in Mice
Xinyu Zhuang et al.
VACCINES (2020)
Airborne transmission of SARS-CoV-2: The world should face the reality
Lidia Morawska et al.
ENVIRONMENT INTERNATIONAL (2020)
COVID-19: Mechanisms of Vaccination and Immunity
Daniel E. Speiser et al.
VACCINES (2020)
COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
Young Hun Chung et al.
ACS NANO (2020)
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
Giovanni Salvatori et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development
Noton K. Dutta et al.
JOURNAL OF VIROLOGY (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
Eskild Petersen et al.
LANCET INFECTIOUS DISEASES (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado et al.
NATURE (2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen et al.
NATURE (2020)
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert et al.
NATURE (2020)
Next-generation vaccine platforms for COVID-19
Debby van Riel et al.
NATURE MATERIALS (2020)
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin et al.
NATURE NANOTECHNOLOGY (2020)
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
Wei Deng et al.
SCIENCE (2020)
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
Paul F. McKay et al.
NATURE COMMUNICATIONS (2020)
Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
Tania Gupta et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection
Shuqin Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y. Logunov et al.
LANCET (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses
Luca Vangelista et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform
Flavia Chiuppesi et al.
NATURE COMMUNICATIONS (2020)
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Drug targets for corona virus: A systematic review
Manisha Prajapat et al.
INDIAN JOURNAL OF PHARMACOLOGY (2020)
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
Guangyu Zhou et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Safety and immunogenicity of a mRNA-based chikungunya vaccine in a phase 1 dose-ranging trial
C. Shaw et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania
Zacchaeus Anywaine et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers
Pablo Tebas et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Robert A Feldman et al.
VACCINE (2019)
Coronavirus envelope protein: current knowledge
Dewald Schoeman et al.
VIROLOGY JOURNAL (2019)
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development
Ayman Mubarak et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Mucosal vaccines and technology
A. Miquel-Clopes et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Novel approaches for the design, delivery and administration of vaccine technologies
J. Wallis et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
A Critical Review of Electroporation as A Plasmid Delivery System in Mouse Skeletal Muscle
Emilia Sokolowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
Kayvon Modjarrad et al.
LANCET INFECTIOUS DISEASES (2019)
Mucosal Vaccination via the Respiratory Tract
Marie Hellfritzsch et al.
PHARMACEUTICS (2019)
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
Margaret A. Liu
VACCINES (2019)
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial
Cristina Carter et al.
PLOS ONE (2019)
Ebola vaccine trials: progress in vaccine safety and immunogenicity
Keesha M. Matz et al.
EXPERT REVIEW OF VACCINES (2019)
A review of Dengvaxia?: development to deployment
Stephen J. Thomas et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Measles-vectored vaccine approaches against viral infections: a focus on Chikungunya
Christiane Gerke et al.
EXPERT REVIEW OF VACCINES (2019)
Nasal route for vaccine and drug delivery: Features and current opportunities
Yadira Lobaina Mato
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Controlling endosomal escape using nanoparticle composition: current progress and future perspectives
Kristofer I. Cupic et al.
NANOMEDICINE (2019)
Novel viral vectors in infectious diseases
Ian R. Humphreys et al.
IMMUNOLOGY (2018)
Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial
Janine R. Danko et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Comparison of Heterosubtypic Protection in Ferrets and Pigs Induced by a Single-Cycle Influenza Vaccine
Barbara Holzer et al.
JOURNAL OF IMMUNOLOGY (2018)
Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape
Lingshu Wang et al.
JOURNAL OF VIROLOGY (2018)
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
Martin R. Gaudinski et al.
LANCET (2018)
Measles-derived vaccines to prevent emerging viral diseases
Phanramphoei N. Frantz et al.
MICROBES AND INFECTION (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Development of novel vaccine vectors: Chimpanzee adenoviral vectors
Jingao Guo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability
A. K. J. Gradel et al.
JOURNAL OF DIABETES RESEARCH (2018)
Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
L. Coughlan et al.
EBIOMEDICINE (2018)
Engineering DNA vaccines against infectious diseases
Jihui Lee et al.
ACTA BIOMATERIALIA (2018)
New Vaccine Technologies to Combat Outbreak Situations
Susanne Rauch et al.
FRONTIERS IN IMMUNOLOGY (2018)
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection
Lorna Leal et al.
AIDS (2018)
DNA VaccinesHow Far From Clinical Use?
Dominika Hobernik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial
Emil C. Reisinger et al.
LANCET (2018)
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial
Katherine Houser et al.
PLOS ONE (2018)
Clinical Advances in Viral-Vectored Influenza Vaccines
Sarah Sebastian et al.
VACCINES (2018)
Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial
Leesun Kim et al.
JCI INSIGHT (2018)
Extracellular RNA Sensing by Pattern Recognition Receptors
Megumi Tatematsu et al.
JOURNAL OF INNATE IMMUNITY (2018)
Viral Vectors: The Road to Reducing Genotoxicity
Rhiannon M. David et al.
TOXICOLOGICAL SCIENCES (2017)
Mechanism of action of mRNA-based vaccines
Carlo Iavarone et al.
EXPERT REVIEW OF VACCINES (2017)
Tissue plasminogen activator (tPA) signal sequence enhances immunogenicity of MVA-based vaccine against tuberculosis
Yiming Kou et al.
IMMUNOLOGY LETTERS (2017)
Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara-Vectored Ebola Vaccines at 1 Year
Rebecca L. Winslow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
Martin Alberer et al.
LANCET (2017)
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2017)
Efficient Targeting and Activation of Antigen Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques
Frank Liang et al.
MOLECULAR THERAPY (2017)
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Kapil Bahl et al.
MOLECULAR THERAPY (2017)
Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates
Merika T. Koday et al.
PLOS ONE (2017)
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Jesper Pallesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Suvasini Ramaswamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
John J. Suschak et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever
Kathleen A. Cashman et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia
I. V. Dolzhikova et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Antibody Immunity Induced by H7N9 Avian Influenza Vaccines: Evaluation Crtera, Affecting Factors, and Implications for Rational Vaccine Design
Zenglei Hu et al.
FRONTIERS IN MICROBIOLOGY (2017)
Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+CXCR3+T Follicular Helper Cells
Gustaf Lindgren et al.
FRONTIERS IN IMMUNOLOGY (2017)
Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trial
G. Haidari et al.
SCIENTIFIC REPORTS (2017)
Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine
Cody S. Lee et al.
GENES & DISEASES (2017)
Current state and challenges in developing oral vaccines
Julia E. Vela Ramirez et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Molecular mechanisms for enhanced DNA vaccine immunogenicity
Lei Li et al.
EXPERT REVIEW OF VACCINES (2016)
Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways
Hin Chu et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
Aline Baldo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Designing liposomal adjuvants for the next generation of vaccines
Yvonne Perrie et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Micro- and nanoparticulates for DNA vaccine delivery
Eric Farris et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Safety and Immunogenicity of Novel Adenovirus Type 26-and Modified Vaccinia Ankara-Vectored Ebola Vaccines A Randomized Clinical Trial
Iain D. Milligan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways
Man Li et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Toll-Like Receptor 7-Targeted Therapy in Respiratory Disease
Katie M. Lebold et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2016)
Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines
S. H. T. Jorritsma et al.
VACCINE (2016)
Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months
Maria Pelliccia et al.
NATURE COMMUNICATIONS (2016)
mRNA vaccine delivery using lipid nanoparticles
Andreas M. Reichmuth et al.
THERAPEUTIC DELIVERY (2016)
Local innate immune responses in the vaccine adjuvant-injected muscle
Frank Liang et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Effect of vaccine administration modality on immunogenicity and efficacy
Lu Zhang et al.
EXPERT REVIEW OF VACCINES (2015)
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
Feng-Cai Zhu et al.
LANCET (2015)
Use of low dose rVSV-ZEBOV: safety issues in a Swiss cohort
Julie E. Ledgerwood
LANCET INFECTIOUS DISEASES (2015)
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial
Katrin Ramsauer et al.
LANCET INFECTIOUS DISEASES (2015)
High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial
David Liebowitz et al.
LANCET INFECTIOUS DISEASES (2015)
An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo
Bin Li et al.
NANO LETTERS (2015)
Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown
Anders Wittrup et al.
NATURE BIOTECHNOLOGY (2015)
Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults
Michelle C. Crank et al.
PLOS ONE (2015)
DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial
Julie E. Ledgerwood et al.
PLOS ONE (2015)
A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates
Karuppiah Muthumani et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis
Jie Zhou et al.
VIROLOGY JOURNAL (2015)
Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation Device
Dinah H. Amante et al.
HUMAN GENE THERAPY METHODS (2015)
Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens
Lassi Liljeroos et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Lipid-based mRNA vaccine delivery systems
Patrick Midoux et al.
EXPERT REVIEW OF VACCINES (2015)
Induction of HIV-1-Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans
Lindsey R. Baden et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology
Yoshikazu Honda-Okubo et al.
JOURNAL OF VIROLOGY (2015)
HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial
Charlotta Nilsson et al.
PLOS ONE (2015)
Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases
Thomas Grunwald et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2015)
Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
William Wold et al.
CURRENT GENE THERAPY (2014)
Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles
Alicia Rodriguez-Gascon et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Endosomal Escape: A Bottleneck in Intracellular Delivery
Harshad K. Shete et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2014)
Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
Richard D. Antrobus et al.
MOLECULAR THERAPY (2014)
Development of Thermostable Lyophilized Inactivated Polio Vaccine
Heleen Kraan et al.
PHARMACEUTICAL RESEARCH (2014)
Rapid generation of a mouse model for Middle East respiratory syndrome
Jincun Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
CORONAVIRUS GENOMICS AND BIOINFORMATICS ANALYSIS
Patrick C. Y. Woo et al.
OMICS IN CLINICAL PRACTICE: GENOMICS, PHARMACOGENOMICS, PROTEOMICS, AND TRANSCRIPTOMICS IN CLINICAL RESEARCH (2014)
Pre-existing immunity against Ad vectors Humoral, cellular, and innate response, what's important?
Hugues Fausther-Bovendo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives
Yingying Xu et al.
Pharmaceutics (2014)
Safety Profile of the Merck Human Immunodeficiency Virus-1 Clade B gag DNA Plasmid Vaccine With and Without Adjuvants
Erin K. Quirk et al.
OPEN FORUM INFECTIOUS DISEASES (2014)
Mucosal dendritic cells shape mucosal immunity
Sun-Young Chang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2014)
Physical Non-Viral Gene Delivery Methods for Tissue Engineering
Adam J. Mellott et al.
ANNALS OF BIOMEDICAL ENGINEERING (2013)
Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection
Maria G. Guzman et al.
ARCHIVES OF VIROLOGY (2013)
Formulation development of lyophilized, long-term stable siRNA/oligoaminoamide polyplexes
Julia Christina Kasper et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)
Lindsey R. Baden et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Alternative Serotype Adenovirus Vaccine Vectors Elicit Memory T Cells with Enhanced Anamnestic Capacity Compared to Ad5 Vectors
Pablo Penaloza-MacMaster et al.
JOURNAL OF VIROLOGY (2013)
Comparative Analysis of Simian Immunodeficiency Virus Gag-Specific Effector and Memory CD8+ T Cells Induced by Different Adenovirus Vectors
Wendy G. Tan et al.
JOURNAL OF VIROLOGY (2013)
Airway Delivery of an Adenovirus-Based Ebola Virus Vaccine Bypasses Existing Immunity to Homologous Adenovirus in Nonhuman Primates
Jason S. Richardson et al.
JOURNAL OF VIROLOGY (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
Gaurav Sahay et al.
NATURE BIOTECHNOLOGY (2013)
GLOBAL HEALTH Designing Tomorrow's Vaccines
Gary J. Nabel
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Therapeutic DNA Vaccination of Vertically HIV-Infected Children: Report of the First Pediatric Randomised Trial (PEDVAC)
Paolo Palma et al.
PLOS ONE (2013)
RNA: The new revolution in nucleic acid vaccines
Andrew J. Geall et al.
SEMINARS IN IMMUNOLOGY (2013)
Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
Joel Meyer et al.
VACCINE (2013)
Vaccines, Reverse Vaccinology, and Bacterial Pathogenesis
Isabel Delany et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Novel vaccine strategies against emerging viruses
Adolfo Garcia-Sastre et al.
CURRENT OPINION IN VIROLOGY (2013)
Tolerability of intramuscular and intradermal delivery by CELLECTRA® adaptive constant current electroporation device in healthy volunteers
Malissa C. Diehl et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
A Seven-Year Storage Report of Good Manufacturing Practice-Grade Naked Plasmid DNA: Stability, Topology, and In Vitro/In Vivo Functional Analysis
Wolfgang Walther et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2013)
Vector Design for Improved DNA Vaccine Efficacy, Safety and Production
James A. Williams
VACCINES (2013)
Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ
Yen Cu et al.
VACCINES (2013)
Viral vectors for vaccine applications
Youngjoo Choi et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2013)
Distribution and Maturation of Skin Dendritic Cell Subsets in Two Forms of Cutaneous T-cell Lymphoma: Mycosis Fungoides and Sezary Syndrome
Philipp Schwingshackl et al.
ACTA DERMATO-VENEREOLOGICA (2012)
Developing vaccines in the era of genomics: a decade of reverse vaccinology
K. L. Seib et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach
Nathaniel D. Lambert et al.
EXPERT REVIEW OF VACCINES (2012)
Pattern-recognition receptors in human eosinophils
Anne Mansson Kvarnhammar et al.
IMMUNOLOGY (2012)
Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
Daniel X. Johansson et al.
PLOS ONE (2012)
Correction: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Chien-Te Tseng et al.
PLoS One (2012)
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
Matthew D. J. Dicks et al.
PLOS ONE (2012)
Nonviral delivery of self-amplifying RNA vaccines
Andrew J. Geall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Developing mRNA-vaccine technologies
Thomas Schlake et al.
RNA BIOLOGY (2012)
Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
Stefano Colloca et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU®-Multi-HIVB, in untreated HIV-1 infected subjects
Eftyhia Vardas et al.
VACCINE (2012)
Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses
Yoshikazu Honda-Okubo et al.
VACCINE (2012)
Vaccines: From Empirical Development to Rational Design
Christine Rueckert et al.
PLOS PATHOGENS (2012)
Viral Vector-Based Therapeutic Cancer Vaccines
Cecilia Larocca et al.
CANCER JOURNAL (2011)
Electroporation delivery of DNA vaccines: prospects for success
Niranjan Y. Sardesai et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
Julie E. Ledgerwood et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Intranasal DNA Vaccination Induces Potent Mucosal and Systemic Immune Responses and Cross-protective Immunity Against Influenza Viruses
Lea Torrieri-Dramard et al.
MOLECULAR THERAPY (2011)
In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers
Sandhya Vasan et al.
PLOS ONE (2011)
The PEDVAC trial: Preliminary data from the first therapeutic DNA vaccination in HIV-infected children
Paolo Palma et al.
VACCINE (2011)
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
Dan H. Barouch et al.
VACCINE (2011)
Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial
Charmagne G. Beckett et al.
VACCINE (2011)
Recent trends in vaccine delivery systems: A review
C. H. Saroja et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION (2011)
Intranasal vaccination with messenger RNA as a new approach in gene therapy: Use against tuberculosis
Julio C. C. Lorenzi et al.
BMC BIOTECHNOLOGY (2010)
Bioadhesive chitosan nanoparticles: Preparation and characterization
Anitha R. Dudhani et al.
CARBOHYDRATE POLYMERS (2010)
Progress and prospects: nuclear import of nonviral vectors
A. P. Lam et al.
GENE THERAPY (2010)
Vaccine Adjuvants: Putting Innate Immunity to Work
Robert L. Coffman et al.
IMMUNITY (2010)
The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Acts as a Dominant Immunogen Revealed by a Clustering Region of Novel Functionally and Structurally Defined Cytotoxic T-Lymphocyte Epitopes
Jun Liu et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Subcutaneous and visceral adipose tissue: structural and functional differences
M. Mohsen Ibrahim
OBESITY REVIEWS (2010)
Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial
Behazine Combadiere et al.
PLOS ONE (2010)
Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients
Zhiliang Cao et al.
VIROLOGY JOURNAL (2010)
Coronavirus Genomics and Bioinformatics Analysis
Patrick C. Y. Woo et al.
VIRUSES-BASEL (2010)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Original Encounter with Antigen Determines Antigen-Presenting Cell Imprinting of the Quality of the Immune Response in Mice
Valerie Abadie et al.
PLOS ONE (2009)
Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen
Jian Yan et al.
VACCINE (2009)
Pulmonary Eosinophilia Is Attenuated by Early Responding CD8+ Memory T Cells in a Murine Model of RSV Vaccine-Enhanced Disease
Whitney W. Stevens et al.
VIRAL IMMUNOLOGY (2009)
Permeation enhancer effect of chitosan and chitosan derivatives: Comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells
A. M. M. Sadeghi et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Overcoming T-cell-mediated immunopathology to achieve safe respiratory syncytial virus vaccination
Elaine M. Castilow et al.
FUTURE VIROLOGY (2008)
Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans
Annika Vogt et al.
JOURNAL OF IMMUNOLOGY (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Mechanisms of disease: Systemic lupus erythematosus
Anisur Rahman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques
Jian Yan et al.
VACCINE (2008)
Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?
Paul Henri Lambert et al.
VACCINE (2008)
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
Julie E. Martin et al.
VACCINE (2008)
Replicating and non-replicating viral vectors for vaccine development
Marjorie Robert-Guroff
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Preservation of DNA
Thomas J. Anchordoquy et al.
CELL PRESERVATION TECHNOLOGY (2007)
Long-term storage of DNA-free RNA for use in vaccine studies
Kathryn L. Jones et al.
BIOTECHNIQUES (2007)
Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor
Silvia Fischer et al.
BLOOD (2007)
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
Vincent C. C. Cheng et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Priming with SARS CoVS DNA and boosting with SARS CoVS epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses
Jun Huang et al.
VACCINE (2007)
Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice
Mary C. Hu et al.
VACCINE (2007)
Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation
Christian Kannemeier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector
Andrew T. Catanzaro et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
Julie E. Martin et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy - a review
Yechiel Becker
VIRUS GENES (2006)
Human memory T cell responses to SARS-CoV E protein
Hui Peng et al.
MICROBES AND INFECTION (2006)
Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, severe acute respiratory syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts
RL Sheets et al.
TOXICOLOGICAL SCIENCES (2006)
Mucosal delivery of vaccine antigens and its advantages in pediatrics
MT De Magistnis
ADVANCED DRUG DELIVERY REVIEWS (2006)
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
FO Nestle et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Effects of multiple copies of CpG on DNA vaccination
AL Zhang et al.
DNA AND CELL BIOLOGY (2005)
Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice
ZJ Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
A novel intranasal Protollin™-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice
S Chabot et al.
VACCINE (2005)
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans
KR Van Kampen et al.
VACCINE (2005)
Isolation of virus from a SARS patient and genome-wide analysis of genetic mutations related to pathogenesis and epidemiology from 47 SARS-CoV isolates
Y Zhu et al.
VIRUS GENES (2005)
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
ZY Yang et al.
NATURE (2004)
Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation
Z Wang et al.
GENE THERAPY (2004)
Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine
P Hai et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Development of stable liquid formulations for adenovirus- based vaccines
RK Evans et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Protollin™:: a novel adjuvant for intranasal vaccines
T Jones et al.
VACCINE (2004)
Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity
UJ Buchholz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Adenoviruses as vaccine vectors
N Tatsis et al.
MOLECULAR THERAPY (2004)
Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system
F Lemiale et al.
JOURNAL OF VIROLOGY (2003)
Structural stability of adenovirus type 5
J Rexroad et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Nasal drug delivery - possibilities, problems and solutions
L Illum
JOURNAL OF CONTROLLED RELEASE (2003)
Mucosal immunization with DNA vaccines
P Hobson et al.
METHODS (2003)
Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses
S Sharpe et al.
VIROLOGY (2002)
Toxicity of a first-generation adenoviral vector in rhesus Macaques
JN Lozier et al.
HUMAN GENE THERAPY (2002)
Development of formulations that enhance physical stability of viral vectors for gene therapy
MA Croyle et al.
GENE THERAPY (2001)
Risk factors for improper vaccine storage and handling in private provider offices
KN Bell et al.
PEDIATRICS (2001)
Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications
GNM Ferreira et al.
TRENDS IN BIOTECHNOLOGY (2000)
Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice
M Dupuis et al.
JOURNAL OF IMMUNOLOGY (2000)
Plasmid DNA vaccines: Investigation of integration into host cellular DNA following intramuscular injection in mice
BJ Ledwith et al.
INTERVIROLOGY (2000)
Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers
TP Le et al.
VACCINE (2000)
The role of CpG motifs in innate immunity
AM Krieg
CURRENT OPINION IN IMMUNOLOGY (2000)
Share Paper
